Kodiak Sciences Inc. 4

Kodiak Sciences Inc. CFO John A. Borgeson received an option award for 66,500 shares of common stock at $42.42 per share on July 15, 2026.

On July 15, 2026, Kodiak Sciences Inc. Chief Financial Officer John A. Borgeson was granted a stock option to purchase 66,500 shares of Kodiak Sciences common stock at an exercise price of $42.42 per share, expiring on July 14, 2036. This equity award appears to be a standard compensation-related option grant, with one-forty-eighth of the shares vesting one month after July 1, 2026, and the remaining shares vesting in forty-seven equal monthly installments thereafter, contingent on his continued service. There were no reported open-market purchases or sales of common stock in this filing, and the post-transaction direct ownership in common stock is reported as 66,500 shares, all tied to this newly granted award.

Filing Facts

CIK

1468748

Ticker

KOD

Form

4

Source Type

fda

Accession

0001754045-26-000008

Alert Tier

5